Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Excellent question. This is a "company-defining" moment. My actions in the next 48 hours will determine whether we survive as a trusted entity or become a case study in corporate malfeasance. My guiding principle is absolute: Patient safety is not negotiable.Read the full answer
The Core Decision (Made Before Hour 1) The side effect is real, serious, and known to me now. Patients are currently taking this drug without informed consent about a ~1-in-8,000 liver failure risk. Everything else — stock price, board pressure, legal exposure — is secondary.Read the full answer